Related Experiment Video
Updated: Jul 27, 2025
10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.2K
[Central serous chorioretinopathy: A review]
E Bousquet1, J Provost2, H Torres-Villaros2
1Départment d'ophtalmologie, hôpital Lariboisière, Assistance publique-Hôpitaux de Paris (AP-HP), université de Paris Cité, Paris, France.
Journal Francais D'Ophtalmologie
|June 5, 2023
Summary
Central serous chorioretinopathy (CSCR) involves fluid under the retina, often linked to pachychoroid diseases. While many cases resolve spontaneously, chronic forms may require treatments like laser or photodynamic therapy to preserve vision.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Choroidopathy
Context:
- Central serous chorioretinopathy (CSCR) is a condition affecting the central retina.
- It is characterized by serous retinal detachments (SRD) and retinal pigment epithelium detachments (PEDs).
- CSCR is associated with choroidal thickening, dilated veins, and hyperpermeability, placing it within the pachychoroid spectrum.
Purpose:
- To describe the key features, risk factors, and clinical course of CSCR.
- To outline the primary treatment modalities for CSCR.
- To highlight the potential for visual impairment in chronic or recurrent cases.
Summary:
- CSCR presents with SRD and PEDs, indicative of an underlying choroidopathy within the pachychoroid spectrum.
- It predominantly affects middle-aged men, with corticosteroid use being a significant risk factor.
- While spontaneous resolution is common, persistent or recurrent CSCR can cause irreversible retinal damage, necessitating interventions like laser or photodynamic therapy.
Impact:
- Provides a concise overview of CSCR for researchers and clinicians.
- Emphasizes the link between CSCR and pachychoroid diseases.
- Informs about the prognosis and treatment options for central serous chorioretinopathy.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
497
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
497
01:28Angle Closure Glaucoma: Treatment
582
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
582
01:25Glaucoma: Overview
633
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
633